Company news
Cytek Biosciences, Inc. news in 2024
Cytek Biosciences, Inc.'s news releases, calls and decks from 2024, newest first.
Cytek Biosciences Announces $50 Million Stock Repurchase Program for 2025
December 29, 2024
Cytek® Biosciences Becomes First Company to Add Ability to Detect Subcellular Particles to Its Cell Sorter
November 6, 2024
Cytek Biosciences Reports Third Quarter 2024 Financial Results
November 4, 2024
Cytek Biosciences to Report Third Quarter 2024 Financial Results on November 5, 2024
October 28, 2024
Cytek Announces Resignation of Chief Operating Officer Chris Williams
September 11, 2024
Cytek® Biosciences Achieves ISO 13485 Certification at San Diego Reagent Manufacturing Facility
August 20, 2024
Cytek Biosciences Reports Second Quarter 2024 Financial Results
August 5, 2024
Cytek® Biosciences Automates Panel Design with New Intelligent Algorithm
July 29, 2024
Cytek Biosciences Announces $50 Million Stock Repurchase Program
June 5, 2024
Cytek Biosciences Reports First Quarter 2024 Financial Results
May 7, 2024
Cytek® Biosciences to Spotlight Cell Analysis Solutions at Upcoming Conferences in the United States and Europe
April 29, 2024
Cytek Biosciences to Report First Quarter 2024 Financial Results on May 8, 2024
April 28, 2024
Cytek® Biosciences Names William McCombe Chief Financial Officer
March 18, 2024
Cytek® Biosciences Opens New Facility to Address Increasing Global Demand for Cutting-Edge Cell Analysis Solutions
March 6, 2024
Cytek Biosciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides 2024 Outlook
February 27, 2024
Cytek Biosciences to Report Fourth Quarter and Full Year 2023 Financial Results on February 28, 2024
February 6, 2024
Cytek® Biosciences Signs Agreement with CRG and UPF to Accelerate Scientific Discoveries
January 16, 2024
Cytek Biosciences Announces Preliminary Full Year 2023 Revenue Results
January 7, 2024